• Info
  • Insider Ownership

Insider Trading & Ownership of Christopher Bowden

Location
Cambridge, MA
Summary
The estimated net worth of Christopher Bowden is at least $341,336 dollars as of 10 Jun 2025. Christopher Bowden is the Chief Medical Officer of AGIOS PHARMACEUTICALS, INC. and owns shares of AGIOS PHARMACEUTICALS, INC. (AGIO) stock worth about $335.1K. Christopher Bowden is the Director of Alaunos Therapeutics, Inc. and owns shares of Alaunos Therapeutics, Inc. (TCRT) stock worth about $6.2K.
Signature
/s/ Lara Meisner, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Christopher Bowden and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Christopher Bowden has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $341,336.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: AGIOS PHARMACEUTICALS, INC. ($335,139).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Christopher Bowden

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AGIO AGIOS PHARMACEUTICALS, INC. Chief Medical Officer $335,139 18 Jun 2021
TCRT Alaunos Therapeutics, Inc. Director $6,197 22 Jun 2022
BCAX Bicara Therapeutics Inc. Director 09 Jun 2025

Insider Transactions Reported by Christopher Bowden:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored